EU experts weigh up medical DEHP risks

Policymakers should consider the potential for replacing the phthalate DEHP in medical devices but must weigh up factors including its usefulness in treatment, experts told the European Commission

The full text of this article is only available to subscribers and free trialists. To login,please enter your email address and subscriber access code below.

Not a subscriber or free trialist? Why not take a free 14 day trial or subscribe today!

Having trouble logging in? Please contact our helpdesk

Back to top Back to top